MARKET

AVTX

AVTX

Avalo Therapeutics Inc
NASDAQ
2.890
+0.090
+3.21%
Closed 16:00 06/02 EDT
OPEN
2.810
PREV CLOSE
2.800
HIGH
2.900
LOW
2.710
VOLUME
9.38K
TURNOVER
14.59K
52 WEEK HIGH
7.41
52 WEEK LOW
1.410
MARKET CAP
38.15M
P/E (TTM)
-0.9853
1D
5D
1M
3M
1Y
5Y
Avalo Therapeutics Inc: Statement of changes in beneficial ownership of securities
Press release · 1d ago
Avalo Therapeutics Inc: Current report
Press release · 1d ago
Avalo Therapeutics Inc: [Cover]SEC-generated letter
Press release · 3d ago
Avalo Therapeutics Inc: Correspondence
Press release · 3d ago
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 05/19 17:21
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 05/18 17:31
PHIO, AVTX and JFU among mid-day movers
Seeking Alpha · 05/18 16:42
RBC Capital Maintains Outperform on Avalo Therapeutics, Lowers Price Target to $9
Benzinga · 05/10 14:43
More
About AVTX
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the treatment of immune dysregulation by developing therapies that target the Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes (LIGHT)-signaling network. Its clinical-stage pipeline includes AVTX-002, AVTX-008, and AVTX-803 programs. AVTX-002 is an Anti-LIGHT monoclonal antibody for treatment of non-eosinophilic asthma, Crohn’s Disease, and COVID-19 acute respiratory distress syndromes. AVTX-008 is a fully human B and T lymphocyte attenuator (BTLA) agonist fusion protein that is being evaluated for several immune dysregulation disorders. AVTX-803 is a monosaccharide therapy for the treatment of leukocyte adhesion deficiency type II (LAD II), which is a congenital disorder of glycosylation (CDG).

Webull offers kinds of Avalo Therapeutics Inc stock information, including NASDAQ:AVTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVTX stock methods without spending real money on the virtual paper trading platform.